Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulation期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulation

Authors:	Daniel B Horton Tobias Gerhard Amy Davidow Brian L Strom

Institution:	1. Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA;2. Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, NJ, USA;3. Department of Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA;4. Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA;5. Department of Biostatistics, Rutgers School of Public Health, Newark, NJ, USA;6. Rutgers Biomedical and Health Sciences, Newark, NJ, USA;7. Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Abstract:

Keywords:	black triangle drug labeling interrupted time series analysis pharmacoepidemiology physicians' practice patterns